Movement Alert｜Medtronic PLC Rises 3.23% in Pre-Market Trading, Bernstein Raises Price Target to $112

Market Focus

Sep 14

On September 14, Medtronic PLC rose 3.23% in pre-market trading, trading at $93.75 USD/share, with turnover of $368,800.

On the news front, Bernstein raised its price target on Medtronic PLC from $105 to $112, maintaining an Outperform rating. The analyst consensus now stands at an average Overweight rating with a mean price target of $104.05. This marks the latest in a series of upward revisions following the company's strong fiscal Q1 results, with UBS previously lifting its target to $110 from $100, BTIG to $100 from $91, and Needham to $114 from $101.

Separately, Medtronic PLC announced an exchange offer to acquire MiniMed shares at up to a 7% discount, capped at 4.5939 MiniMed shares per Medtronic share, signaling continued capital management activity following the diabetes business separation. Fundamentally, the company reported FY27 Q1 revenue of $9.76 billion, up 13.8% year-over-year, with cardiovascular sales surging 18.9%. Management raised full-year adjusted EPS guidance to $5.94-$6.00, with the lower bound already exceeding the prior Wall Street consensus of $5.95.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/news/1173201688"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1173201688\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1173201688?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-14 19:57","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1173201688","market":"hk","top_or_hot":-1,"title":"Movement Alert｜Medtronic PLC Rises 3.23% in Pre-Market Trading, Bernstein Raises Price Target to $112","media":"Market Focus","content":"<p><p>On September 14, Medtronic PLC rose 3.23% in pre-market trading, trading at $93.75 USD/share, with turnover of $368,800.</p><p>On the news front, Bernstein raised its price target on Medtronic PLC from $105 to $112, maintaining an Outperform rating. The analyst consensus now stands at an average Overweight rating with a mean price target of $104.05. This marks the latest in a series of upward revisions following the company's strong fiscal Q1 results, with UBS previously lifting its target to $110 from $100, BTIG to $100 from $91, and Needham to $114 from $101.</p><p>Separately, Medtronic PLC announced an exchange offer to acquire MiniMed shares at up to a 7% discount, capped at 4.5939 MiniMed shares per Medtronic share, signaling continued capital management activity following the diabetes business separation. Fundamentally, the company reported FY27 Q1 revenue of $9.76 billion, up 13.8% year-over-year, with cardiovascular sales surging 18.9%. Management raised full-year adjusted EPS guidance to $5.94-$6.00, with the lower bound already exceeding the prior Wall Street consensus of $5.95.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Medtronic PLC Rises 3.23% in Pre-Market Trading, Bernstein Raises Price Target to $112</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Medtronic PLC Rises 3.23% in Pre-Market Trading, Bernstein Raises Price Target to $112\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-09-14 19:57</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On September 14, Medtronic PLC rose 3.23% in pre-market trading, trading at $93.75 USD/share, with turnover of $368,800.</p><p>On the news front, Bernstein raised its price target on Medtronic PLC from $105 to $112, maintaining an Outperform rating. The analyst consensus now stands at an average Overweight rating with a mean price target of $104.05. This marks the latest in a series of upward revisions following the company's strong fiscal Q1 results, with UBS previously lifting its target to $110 from $100, BTIG to $100 from $91, and Needham to $114 from $101.</p><p>Separately, Medtronic PLC announced an exchange offer to acquire MiniMed shares at up to a 7% discount, capped at 4.5939 MiniMed shares per Medtronic share, signaling continued capital management activity following the diabetes business separation. Fundamentally, the company reported FY27 Q1 revenue of $9.76 billion, up 13.8% year-over-year, with cardiovascular sales surging 18.9%. Management raised full-year adjusted EPS guidance to $5.94-$6.00, with the lower bound already exceeding the prior Wall Street consensus of $5.95.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MDT","symbol_name":"美敦力","start_time":0,"source_url":"","article_id":"1173201688","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1173201688","pubTimestamp":1789387047,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On September 14, Medtronic PLC rose 3.23% in pre-market trading, trading at $93.75 USD/share, with turnover of $368,800.On the news front, Bernstein raised its price target on Medtronic PLC from $105...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MDT":"美敦力"},"translate_title":"走势警报|美敦力 PLC 盘前交易上涨 3.23%，伯恩斯坦将目标价上调至 112 美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MDT":1},"content_text":"On September 14, Medtronic PLC rose 3.23% in pre-market trading, trading at $93.75 USD/share, with turnover of $368,800.On the news front, Bernstein raised its price target on Medtronic PLC from $105 to $112, maintaining an Outperform rating. The analyst consensus now stands at an average Overweight rating with a mean price target of $104.05. This marks the latest in a series of upward revisions following the company's strong fiscal Q1 results, with UBS previously lifting its target to $110 from $100, BTIG to $100 from $91, and Needham to $114 from $101.Separately, Medtronic PLC announced an exchange offer to acquire MiniMed shares at up to a 7% discount, capped at 4.5939 MiniMed shares per Medtronic share, signaling continued capital management activity following the diabetes business separation. Fundamentally, the company reported FY27 Q1 revenue of $9.76 billion, up 13.8% year-over-year, with cardiovascular sales surging 18.9%. Management raised full-year adjusted EPS guidance to $5.94-$6.00, with the lower bound already exceeding the prior Wall Street consensus of $5.95.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}